| [1] |
Parkin DM,Bray F,Ferlay J,et al. Global cancer statistics,2002[J]. CA Cancer J Clin,2005,55(2):74-108.
|
| [2] |
Veeck J,Esteller M. Breast cancer epigenetics: from DNA methylation to microRNAs[J]. J Mammary Gland Biol Neoplasia,2010,15(1):5-17.
|
| [3] |
Korkola J,Gray JW. Breast cancer genomes--form and function[J]. Curr Opin Genet Dev,2010,20(1):4-14.
|
| [4] |
Jovanovic J,Ronneberg JA,Tost J,et al. The epigenetics of breast cancer[J]. Mol Oncol,2010,4(3):242-254.
|
| [5] |
Wolffe AP,Matzke MA. Epigenetics: Regulation through repression[J]. Science,1999,286(5439):481-486.
|
| [6] |
Chuang JC,Jones PA. Epigenetics and microRNAs[J]. Pediatric Research,2007,61(5):24-29.
|
| [7] |
Hinshelwood RA,Clark SJ. Breast cancer epigenetics: normal human mammary epithelial cells as a model system[J]. J Mol Med,2008,86(12):1315-1328.
|
| [8] |
Jones PA,Baylin SB. The epigenomics of cancer[J]. Cell,2007. 128(4):683-692.
|
| [9] |
Eden A,Gaudet F,Waghmare A,et al. Chromosomal instability and tumors promoted by DNA hypomethylation[J]. Science,2003,300(5618):455.
|
| [10] |
Ehrlich M. DNA hypomethylation,cancer,the immunodeficiency,centromeric region instability,facial anomalies syndrome and chromosomal rearrangements[J]. J Nutr,2002,132(8 Suppl): S2424-S2429.
|
| [11] |
Pakneshan P,Szyf M,Farias Eisner R,et al.,Reversal of the hypomethylation status of urokinase (uPA) promoter blocks breast cancer growth and metastasis[J]. J Biol Chem,2004,279(30):31735-3144.
|
| [12] |
Fan M,Yan PS,Hartman Frey C,et al. Diverse gene expression and DNA methylation profiles correlate with differential adaptation of breast cancer cells to the antiestrogens tamoxifen and fulvestrant [J]. Cancer Res,2006,66(24):11954-1166.
|
| [13] |
Martens JWM,Margossian AL,Schmitt M,et al. DNA methylation as a biomarker in breast cancer[J]. Future Oncol,2009,5(8):1245-1256.
|
| [14] |
Lo PK,Sukumar S. Epigenomics and breast cancer. Pharma-cogenomics,2008,9(12):1879-1902.
|
| [15] |
Sharma G,Mirza S,Parshad R,et al. CpG hypomethylation of MDR1 gene in tumor and serum of invasive ductal breast carcinoma patients[J]. Clin Biochem,2010,43(4/5):373-379.
|
| [16] |
Widschwendter M,Apostolidou S,Raum E,et al. Epigenotyping in peripheral blood cell DNA and breast cancer risk: a proof of principle study[J]. PLoS One,2008,3(7):e2656.
|
| [17] |
Muller HM,Widschwendter A,Fiegl H,et al. DNA methylation in serum of breast cancer patients: an independent prognostic marker[J]. Cancer Res,2003,63(22):7641-7645.
|
| [18] |
Li Y,Wei Q,Cao F,et al. Expression and promoter methylation of the RASSF1A gene in sporadic breast cancers in Chinese women[J]. Oncol Rep,2008,19(5):1149-1153.
|
| [19] |
Lewis CM,Cler LR,Bu DW,et al. Promoter hypermethylation in benign breast epithelium in relation to predicted breast cancer risk[J]. Clin Cancer Res,2005,11(1):166-172.
|
| [20] |
Kim JH,Shin MH,Kweon SS,et al. Evaluation of promoter hypermethylation detection in serum as a diagnostic tool for breast carcinoma in Korean women[J]. Gynecol Oncol,2010,118(2):176-181.
|
| [21] |
Ahmed IA,Pusch CM,Hamed T,et al. Epigenetic alterations by methylation of RASSF1A and DAPK1 promoter sequences in mammary carcinoma detected in extracellular tumor DNA[J]. Cancer Genet Cytogenet,2010,199(2):96-100.
|
| [22] |
Van der Auwera I,Bovie C,Svensson C,et al. Quantitative methylation profiling in tumor and matched morphologically normal tissues from breast cancer patients[J]. BMC Cancer,2010,10:97.
|
| [23] |
Wilson ME,Westberry JM. Regulation of oestrogen receptor gene expression: new insights and novel mechanisms[J]. J Neuroendocrinol,2009,21(4):238-242.
|
| [24] |
Fiegl H,Millinger S,Mueller Holzner E,et al. Circulating tumor-specific DNA: a marker for monitoring efficacy of adjuvant therapy in cancer patients[J]. Cancer Res,2005,65(4):1141-1145.
|
| [25] |
Fiegl H,Jones A,Hauser Kronberger C,et al. Methylated NEUROD1 promoter is a marker for chemosensitivity in breast cancer[J]. Clin Cancer Res,2008,14(11):3494-3502.
|
| [26] |
Dietrich D,Krispin M,Dietrich J,et al. CDO1 promoter methylation is a biomarker for outcome prediction of anthracycline treated,estrogen receptor-positive,lymph node-positive breast cancer patients[J]. BMC Cancer,2010,10:247.
|
| [27] |
Karray Chouayekh S,Trifa F,Khabir A,et al. Aberrant methylation of RASSF1A is associated with poor survival in Tunisian breast cancer patients[J]. J Cancer Res Clin Oncol,2010,136(2):203-210.
|
| [28] |
Campan M,Weisenberger DJ,Laird PW. DNA methylation profiles of female steroid hormone-driven human malignancies[J].Curr Top Microbiol Immunol,2006,310:141-178.
|
| [29] |
Dworkin AM,Huang THM,Toland AE. Epigenetic alterations in the breast: Implications for breast cancer detection,prognosis and treatment[J]. Semin Cancer Biol,2009,19(3):165-171.
|
| [30] |
Sharma G,Mirza S,Parshad R,et al. Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients[J]. Life Sci,2010,87(3/4):83-91.
|
| [31] |
Jing F,Jun L,Yong Z,et al. Multigene methylation in serum of sporadic Chinese female breast cancer patients as a prognostic biomarker[J]. Oncology,2008,75(1/2):60-66.
|
| [32] |
Evron E,Dooley WC,Umbricht CB,et al. Detection of breast cancer cells in ductal lavage fluid by methylation-specific PCR[J]. Lancet,2001,357(9265):1335-1336.
|
| [33] |
Fackler MJ,McVeigh M,Mehrotra J,et al. Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer[J]. Cancer Res,2004,64(13):4442-4452.
|
| [34] |
Fackler MJ,Malone K,Zhang Z,et al. Quantitative multiplex methylation-specific PCR analysis doubles detection of tumor cells in breast ductal fluid[J]. Clin Cancer Res,2006,12(11 Pt 1):3306-3310.
|
| [35] |
Jing F,Yuping W,Yong C,et al. CpG island methylator phenotype of multigene in serum of sporadic breast carcinoma[J].Tumour Biol,2010,31(4):321-331.
|
| [36] |
Brooks J,Cairns P,Zeleniuch Jacquotte A. Promoter methylation and the detection of breast cancer[J]. Cancer Causes Control,2009,20(9):1539-1550.
|